SCHEMBL23960253

SCHEMBL23960253

Nc1c(O)csc1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9230362 0.69
SCHEMBL17372874 0.61
SCHEMBL7855237 0.56 ALOX15 (0.42)
SCHEMBL29689091 0.56 ALOX15 (0.42)
SCHEMBL9008984 0.55 IDO1 (0.40)
SCHEMBL5150544 0.55
Hydrochloric Acid SCHEMBL28756357 0.54 ALOX15 (0.40)
SCHEMBL19511839 0.54 ALDH1A1 (0.39)
SCHEMBL2119679 0.53 TSHR (0.35)
SCHEMBL1760834 0.53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021214117-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF IOMX THERAPEUTICS AG (DE) 2021-10-28 WO disclosed
EP-3901151-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF iOmx Therapeutics AG (DE) 2021-10-27 EP disclosed